Welcome To IANS Live - NATION - Hetero's Covid-19 oral drug

This is the first pre-qualification for a generic version of Pfizer's Covid-19 oral antiviral drug 'Paxlovid', which the WHO called, the best therapeutic choice for high-risk patients to date.WHO

Related Keywords

Hyderabad , Andhra Pradesh , India , Charles Gore , Vamsi Krishna Bandi , Pfizer , Hetero Group Of Companies , World Health Organization Prequalification Of Medicines Programme , World Health Organization Prequalification , Medicines Programme , Managing Director , Hetero Group , Medicines Patent Pool , Middle Income Countries , Executive Director , Emergency Use Authorization , Drugs Controller General , Nirmatrelvir , Ritonavir , Hetero , Nirmacom , Patients , Available , Generic , Version , Pfizers , Director ,